Roivant Sciences (ROIV) Current Taxes (2022 - 2026)
Roivant Sciences' (ROIV) quarterly Current Taxes came in at $74.2 million in Q2 2026, up 62.36% quarter-over-quarter from $45.7 million in Q1 2026.
Analysis
Roivant Sciences (ROIV) Current Taxes (2022 - 2026) Analysis & Trends
Roivant Sciences (ROIV) has reported Current Taxes for 5 consecutive years, with $74.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Taxes changed N/A year-over-year to $74.2 million; the trailing twelve-month figure through Jun 2026 stood at $74.2 million (changed N/A YoY), and the FY2026 full-year result was $45.7 million, up 10882.93% from the prior year.
- Current Taxes climbed to $74.2 million in Q2 2026 per ROIV's latest filing, from $45.7 million in the prior quarter.
- Across five years, Current Taxes topped out at $74.2 million in Q2 2026 and bottomed at $416000.0 in Q1 2025.
- Historically, Current Taxes has averaged $14.9 million across 5 years, with a median of $5.4 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Current Taxes sank 97.72% in 2024, then surged 10882.93% in 2026.
- Over 5 years, Current Taxes stood at $5.6 million in 2022, then soared by 347.45% to $25.2 million in 2023, then tumbled by 97.72% to $576000.0 in 2024, then dropped by 27.78% to $416000.0 in 2025, then surged by 17732.21% to $74.2 million in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $74.2 million, $45.7 million, and $416000.0 for Q2 2026, Q1 2026, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.68 Bn | 197.69 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.84 Bn | 177.66 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.50 Bn | 74.50 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.49 Bn | 56.31 Bn | 1.37 Bn | 49.00 Mn |
| 6 | Moderna | 55.01 Bn | 49.87 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.08 Bn | 30.77 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.35 Bn | 30.06 Bn | 1.96 Bn | 86.90 Mn |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn | 74.18 Mn |
| 10 | Insmed | 27.84 Bn | 26.68 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.18 Mn |
| Mar 31, 2026 | 45.69 Mn |
| Mar 31, 2025 | 416,000.00 |
| Dec 31, 2024 | 576,000.00 |
| Sep 30, 2024 | 5.41 Mn |
| Jun 30, 2024 | 23.44 Mn |
| Mar 31, 2024 | 9.77 Mn |
| Dec 31, 2023 | 25.22 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 542,000.00 |
| Dec 31, 2022 | 5.64 Mn |
| Mar 31, 2022 | 708,000.00 |